The FDA Announces a Recall of This Children's Cough Syrup Dating Back to 2022
The five affected lots were distributed in the US both online and in retail stores from Dec. 14, 2022, to June 4, 2025. The lot numbers are 0039, 0545, 0640, 0450 and 1198, while the affected expiration dates extend to December 2026.
The FDA reports that "no serious adverse events have been reported to date."
This cough syrup contains three ingredients: honey, purified water and a natural preservative.
Amazon
If you purchased a Little Remedies Honey Cough Syrup that has been recalled, stop using it immediately. If your child has experienced any issues that may be related to this product, contact their doctor. For reimbursement, you can email Medtech at medicalaffairs@prestigebrands.com, contact via its website at or by phone at (800) 754-8853, Monday through Friday from 8:30 a.m. to 5:30 p.m. Eastern time.
Any reactions or quality issues can be reported to the FDA's MedWatch Adverse Event Reporting program.
What is Bacillus cereus?
The FDA reports that Bacillus cereus or B. cereus is a bacterium that can cause two types of foodborne illnesses.
The first type can start 1 to 6 hours after consumption of the contaminated food or drink. Symptoms include: stomach cramps, vomiting and nausea.
The second type of foodborne illness that Bacillus cereus causes can occur 8 to 16 hours after consumption. Its symptoms are diarrhea and stomach cramps.
"Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death," the FDA said.
If your child is demonstrating any of these symptoms related to the consumption of Little Remedies Honey Cough Syrup, contact their doctor immediately.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
17 minutes ago
- Bloomberg
Apple Watch Blood Oxygen Tracker Returns to US After Legal Win
Apple Inc.'s blood oxygen tracking feature for its smartwatch is returning to the US after a yearslong legal fight. The feature — which was removed at the end of 2023 due to a patent infringement lawsuit by Masimo Corp. and a US Customs injunction — will return for Apple Watch owners who bought models with the feature disabled, Apple said in a statement on Thursday.
Bloomberg
17 minutes ago
- Bloomberg
Lilly Hikes UK Obesity Shot Price as Trump Pressures Drugmakers
Photographer: George Frey/Bloomberg Eli Lilly & Co. is raising the list price for its obesity shot in the UK, as the pharma industry comes under pressure from US President Donald Trump to increase medicine prices in Europe and lower them for Americans. The current list price in the UK for Lilly's obesity drug Mounjaro ranges from £92 ($124.89) to £122 a month, depending on the dose. The new list price will see this increase to between £133 and £330 from Sept. 1, with the US drugmaker saying it aims to bring rates in line with other countries.
The Verge
17 minutes ago
- The Verge
Apple returns blood oxygen monitoring to the latest Apple Watches
Blood oxygen monitoring is returning to the Apple Watch — sort of. Starting today, Apple is rolling out a software update that enables a redesigned version of the feature for the Apple Watch Series 9, 10, and Ultra 2 that circumvents the import ban imposed by the International Trade Commission. To get around the ban, blood oxygen data collected on the Watch will now be measured and calculated on the iPhone that it's paired to. While users won't be able to view the data on their wrist, they'll be able to view it in the iPhone's Health app under the Respiratory section. Apple's announcement states that US customs has ruled that the company will be able to import watches with this redesigned feature. This redesign only covers Apple Watches sold after January 17th, 2024, once the ITC import ban took full effect. It doesn't impact models sold before that date or watches sold outside the US, all of which still have the original blood oxygen feature. You can tell if you have a covered model by checking if the serial number ends with LW/A. To get the redesigned feature, people with Series 9, 10, and Ultra 2 watches will have to update their devices to watchOS 11.6.1 and their iPhones to iOS 18.6.1. Apple has been in a lengthy legal dispute with Masimo, a medical device maker known for its pulse oximeters. Masimo alleged that Apple had infringed on several of its patents, filing a suit in 2020 accusing the company of stealing trade secrets. Masimo separately filed a case with the ITC in 2021, which culminated in an import ban in December 2023. Apple has also lodged suits against Masimo over its smartwatches, which it claims are Apple Watch clones. It also filed a 916-page appeal of the ITC ban. That appeal is currently ongoing and Masimo's patents are set to expire in 2028. Posts from this author will be added to your daily email digest and your homepage feed. See All by Victoria Song Posts from this topic will be added to your daily email digest and your homepage feed. See All Apple Posts from this topic will be added to your daily email digest and your homepage feed. See All Gadgets Posts from this topic will be added to your daily email digest and your homepage feed. See All Health Posts from this topic will be added to your daily email digest and your homepage feed. See All News Posts from this topic will be added to your daily email digest and your homepage feed. See All Science Posts from this topic will be added to your daily email digest and your homepage feed. See All Smartwatch Posts from this topic will be added to your daily email digest and your homepage feed. See All Tech Posts from this topic will be added to your daily email digest and your homepage feed. See All Wearable
